Article info
PDFArrhythmias and sudden death
Original research
Premature permanent discontinuation of apixaban or warfarin in patients with atrial fibrillation
- Correspondence to Professor Christopher B Granger, Duke Clinical Research Institute, Durham, NC 27701, USA; christopher.granger{at}duke.edu
Citation
Premature permanent discontinuation of apixaban or warfarin in patients with atrial fibrillation
Publication history
- Received April 29, 2020
- Revised July 21, 2020
- Accepted July 28, 2020
- First published September 16, 2020.
Online issue publication
April 12, 2021
Article Versions
- Previous version (16 September 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.